[EN] 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS<br/>[FR] DERIVES DE 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE UTILISES COMME INHIBITEURS DE LA KINASE, EN PARTICULIER COMME INHIBITEURS DE LA KINASE SRC
申请人:BAYER AG
公开号:WO2003026666A1
公开(公告)日:2003-04-03
The invention provides novel substituted 2,4-diaminopyrimidine compounds (I), in which L is a linker selected from: -O-(CH2)1-4- ; s(O)0-2-(CH2)1-4- ; -N(R1)-(CH2)1-4-(CH2)1-4-O-(CH2)1-4- ; -N(R1)-C(O)-(CH¿2?)1-4- ; (I) and (I) G represents: Alternatively, L may represent (I) or (I), and in this event, G represents (I) and pharmaceutical compositions thereof. The invention also provides methods of use of the novel substituted 2,4-diaminopyrimidine compounds and pharmaceutical compositions thereof as inhibitors of src kinase enzymes. Exemplary diseases that can be treated by the compounds of the invention include cell proliferative diseases, such as cancer and non-malignant cell proliferative diseases, osteoporosis and inflammatory diseases. Also provided are methods for preparing the compounds of the present invention.